Spatial Scene Recognition Memory in Epilepsy Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-55
SponsorUniversity of California, Davis

About this trial

This study investigates the anatomical and physiological basis of spatial scene recognition memory in patients with temporal lobe epilepsy and temporal lobe lesions. Standard neuropsychological tests are insensitive to important memory deficits experienced by patients, particularly in spatial/scene memory, recollective experience, and familiarity processing. Using a validated virtual tour paradigm, the study examines how familiarity-based recognition and recall of spatial scenes relate to specific brain structures. In Aim I, a large cohort of patients with varied temporal lobe lesions at Emory University undergoes the virtual tour task with voxel-based lesion-symptom mapping to localize necessary brain regions. In Aim II, scalp event-related potentials and eye tracking in healthy participants at UC Davis characterize the temporal dynamics and lateralization of scene recognition. In Aim III, intracranial EEG recordings (including local field potentials and single-unit activity) in epilepsy surgery patients at UC Davis determine the precise network dynamics underlying spatial scene familiarity and recall. The long-term goal is to improve the prediction and prevention of cognitive morbidity from epilepsy surgery by providing a more complete model of spatial recognition memory circuits.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 18 years or older

For Aims I and III: Diagnosis of focal epilepsy or temporal lobe lesion; patients undergoing evaluation for or having undergone epilepsy surgery

For Aim II: Healthy adult participants

Full-Scale IQ ≥ 70

Disqualifiers

Full-Scale IQ < 70

Inability to provide informed consent

For Aim III: Age > 55 years

For Aim II: History of neurological or psychiatric disorder (as applicable per study protocol)

Trial design

Design model

Parallel

Treatments tested in this trial

  • Virtual Tour Recognition Memory Task

    Behavioral

    Participants are passively navigated through virtual tour scenes (5-second video clips) during a study phase and are asked to generate descriptive names for each scene. During the test phase, they view novel, spatially similar (same configuration, different objects), or identical scenes and rate familiarity, indicate old/new judgments, report déjà vu sensations, and attempt to recall scene names. The task consists of two study-test blocks. This is a cognitive/behavioral assessment, not a therapeutic intervention.

  • Intracranial EEG Recording with Research Electrodes (Aim III only)

    Device

    Patients undergoing clinically indicated stereoelectroencephalography (SEEG) for seizure localization have electrodes implanted at locations determined solely by clinical need. In a subset of patients, FDA-approved research electrodes (Dixi micro-macro electrodes or Behnke-Fried As-Tech electrodes with tetrode components) substitute standard clinical electrodes at the same clinically determined locations. These electrodes have the same geometry as clinical electrodes and are FDA-approved. The tetrode component enables single-neuron recording for research purposes and adds no additional risk. Electrode placement is not altered by study participation. Local field potentials (LFP) and, where available, single-unit data are recorded during the virtual tour task and resting state.

  • MRI Neuroimaging and Neuropsychological Assessment (Aim I)

    Diagnostic test

    Pre- and post-surgical structural MRI (T1-weighted, diffusion-weighted imaging, resting-state fMRI) obtained as part of the clinical epilepsy surgery evaluation at Emory University. Extensive neuropsychological battery administered pre- and post-operatively (6 months and 1 year) including Wechsler memory scales, Rey-Osterrieth Complex Figure, confrontation naming, and additional measures.

Treatment groups

620 Participants
are divided into 3 treatment groups
Group A: Aim I: Lesion-Symptom MappingExperimental treatment 2 interventions
Group B: Aim II: Scalp ERP StudyExperimental treatment 1 intervention
Group C: Aim III: Intracranial EEGExperimental treatment 2 interventions

Trial outcomes

Primary outcomes

1

Scene familiarity discrimination accuracy

Rate of correct familiarity judgments for spatially similar test scenes versus novel scenes (recognition without identification/RWI effect), measured as the proportion of "familiar" responses to configurally matched scenes minus false alarm rate to novel scenes.

Time frame
From enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)
2

Scene recall accuracy

Proportion of test scenes for which participants correctly recall the name or identifying details of the corresponding study scene (verified recall), separately for identical repeat scenes and configurally similar scenes.

Time frame
From enrollment until the end of eight weeks, during which time testing is scheduled (Aim II), or during the hospitalization for invasive EEG studies (Aim III). Participants in Aim I can undergo repeat testing (six months, one year, etc.)
3

Lesion-symptom correlation for familiarity and recall (Aim I)

Voxel-based lesion-symptom mapping (VBLSM) correlating surgical lesion volumes in temporal lobe subregions (temporopolar, perirhinal, entorhinal, parahippocampal, hippocampal) with familiarity and recall behavioral scores.

Time frame
Testing is scheduled within eight weeks of enrollment for all patients, with repeat testing at six and 12 months after surgery for those enrolled pre-operatively
4

ERP amplitude and latency associated with familiarity and recall (Aim II)

Amplitude and latency of event-related potential components (FN400, late positive component) in specified scalp regions (e.g., LAS, RAS, LPS, RPS) as a function of scene familiarity and recall conditions.

Time frame
During EEG recording session

Secondary outcomes

1

Déjà vu report rate

Proportion of test trials in which participants report a feeling of déjà vu, analyzed by scene condition (similar, repeat, novel).

Time frame
During testing sessions with the virtual tour
2

Vividness of Visual Imagery Questionnaire, Second Edition (VVIQ-2) scores (Aim I)

Self-reported vividness of visual imagery correlated with lesion location and recognition memory performance. The VVIQ-2 is a 32-item self-report questionnaire in which each item is rated on a scale from 1 (no image at all) to 5 (perfectly clear and vivid). Total scores range from 32 to 160. Higher scores indicate more vivid visual imagery.

Time frame
During testing session
3

Hyperfamiliarity commission errors

Rate of false positive familiarity judgments for novel scenes (false alarms), as a measure of hyperfamiliarity.

Time frame
During testing session
4

Neuropsychological test performance (Aim I)

Standard neuropsychological battery scores (Wechsler Memory Scale, Rey-Osterrieth Complex Figure, confrontation naming, etc.) correlated with virtual tour performance and lesion characteristics.

Time frame
Pre-surgery and 6 months / 1 year post-surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.